Sarilumab beneficial for polymyalgia rheumatica patients

For patients with polymyalgia rheumatica with relapse during tapering of glucocorticoid therapy, treatment with sarilumab, the human monoclonal antibody that binds to the interleukin-6 receptor α, is efficacious for achieving ...

Oncology & Cancer

Trial shows promise for new antibody cancer treatment

The first ever clinical trial of a new class of immunotherapy for cancer has shown promising results that could benefit patients who do not respond to existing cancer treatments.

page 2 from 34